Form 4: Phibro Animal Health CEO Sells $834K in Stock

Phibro Animal Health's President and CEO, Jack Bendheim, along with BFI Co., LLC, sold 20,664 shares of Class A Common Stock for approximately $834,000 under a pre-arranged 10b5-1 trading plan.

Summary

• Jack Bendheim, President and CEO, Director, and 10% Owner of Phibro Animal Health Corp (PAHC), along with BFI Co., LLC, a 10% owner, reported a sale of Class A Common Stock.
• A total of 20,664 shares were sold on September 30, 2025, at a weighted average price of $40.38 per share.
• The total value of the shares sold amounts to approximately $834,000.
• The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC on May 30, 2025.
• Following the transaction, BFI Co., LLC indirectly holds 40,674 shares, and Jack Bendheim directly holds 16,840 shares of Class A Common Stock.
• The shares were sold in multiple transactions within a price range of $40.00 to $40.635 per share.

Sentiment

Score: 4

Explanation: The sale by a key executive and a 10% owner, even under a 10b5-1 plan, can be viewed with slight caution by the market. While pre-planned, it still represents a reduction in insider holdings. The lack of additional context in a Form 4 prevents a stronger positive or negative sentiment.

Negatives

• The President and CEO, a Director, and a 10% owner, along with a related entity, sold a significant number of shares, which could be perceived negatively by investors.

Risks

• Insider selling, even under a 10b5-1 plan, can sometimes be interpreted by the market as a lack of confidence in the company's future prospects, potentially leading to downward pressure on the stock price.

Future Outlook

The filing does not contain any explicit forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI Co., LLC and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Industry Context

This Form 4 filing reports an insider transaction and does not provide broader industry context or analysis. It reflects a specific stock sale by a key executive and a related entity within the animal health sector.

Corporate Governance

Related Party Transactions

• The sale of 20,664 shares of Class A Common Stock was conducted by BFI Co., LLC, a 10% owner, over which Jack Bendheim, President and CEO, Director, and 10% Owner, exercises voting and dispositive power. This constitutes a transaction involving related parties.

Stakeholder Impact

• Shareholders may interpret the insider sale as a signal regarding management's view of the company's valuation or future prospects, potentially influencing their investment decisions.
• The use of a 10b5-1 plan provides transparency and predictability for the market regarding executive stock sales, which can be beneficial for investor confidence.

Key Dates

Keywords

Phibro Animal Health, PAHC, Jack Bendheim, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction, CEO Stock Sale, Animal Health